CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-03 | Domzalski David President and CEO | Grant or award | +249,588 | 578,985 | ||
| 2020-04-03 | Bruno Anthony D Director | Grant or award | +75,690 | 120,123 | ||
| 2020-04-03 | Bruno Anthony D Director | Grant or award | +14,933 | 135,056 | ||
| 2020-04-03 | Basta Steven L Director | Grant or award | +14,499 | 536,537 | ||
| 2020-03-31 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,688 | $2.68 | $5K | 56,503 |
| 2020-03-31 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −525 | $2.68 | $1K | 67,051 |
| 2020-03-31 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −1,940 | $2.68 | $5K | 59,452 |
| 2020-03-31 | Domzalski David President and CEO | Shares withheld for taxes | −4,456 | $2.68 | $12K | 187,496 |
| 2020-03-23 | Saik Andrew Chief Financial Officer | Grant or award | +50,000 | 50,000 | ||
| 2020-03-23 | Saik Andrew Chief Financial Officer | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2020-03-19 | Sandoval Elisabeth Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2020-03-19 | Bruno Anthony D Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2020-03-19 | Bright Rex Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2020-03-19 | Basta Steven L Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2020-03-19 | BARBARI SHARON SURREY Director | Grant or award · Stock Option | +45,000 | 45,000 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +20,896 | 20,896 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +46,680 | 67,576 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +59,240 | 59,240 | ||
| 2020-03-09 | Wiley Matthew T. Chief Commercial Officer | Grant or award · Stock Options | +57,086 | 57,086 | ||
| 2020-03-09 | Stuart Iain Chief Scientific Officer | Grant or award | +7,306 | 7,306 |
Page 14 of 22 · 425 trades